FDA Approves Horizant for Restless Leg Syndrome
Links shared publicly online about this topic
Horizant Approved for Restless Legs Syndrome - MPR
empr.com — “GlaxoSmithKline and XenoPort announced that the FDA has approved Horizant (gabapentin enacarbil extended-release tablets) for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults.” View full resource at empr.com
Most Recently Shared on April 8, 2011 at 3:09 pm By:
MPR News: Horizant Approved for Restless Legs Syndrome: GlaxoSmithKline and XenoPort announced that the FDA has ... http://bit.ly/goDK15
Horizant for Restless Legs Syndrome FDA Approved
disabled-world.com — “FDA approved drug Horizant provides significant help in treating restless legs syndrome symptoms” View full resource at disabled-world.com
Most Recently Shared on April 10, 2011 at 4:53 pm By:
Disabled World Health Advocate and Health News
Horizant for Restless Legs Syndrome FDA Approved http://ff.im/-AOmPw
Horizant Approved for Restless Legs Syndrome - ONA
oncologynurseadvisor.com — “GlaxoSmithKline and XenoPort announced that the FDA has approved Horizant (gabapentin enacarbil extended-release tablets) for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 8, 2011 at 2:43 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Horizant Approved for Restless Legs Syndrome http://goo.gl/fb/lDV5G
FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome
news-medical.net — “GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.” View full resource at news-medical.net
Most Recently Shared on April 7, 2011 at 8:53 am By:
Parkinson's Disease: FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome: GlaxoSmithKline ... http://bit.ly/fRCsTv
Horizant Approved to Treat Restless Legs Syndrome --Doctors Lounge
doctorslounge.com — “Horizant Approved to Treat Restless Legs Syndrome --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on April 7, 2011 at 4:14 pm By:
Horizant Approved to Treat Restless Legs Syndrome: Possible side effects include drowsiness and dizziness http://bit.ly/eSEdmA
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 14, 2011 at 4:24 pm By:
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/w7lzkW8
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 13, 2011 at 4:09 am By:
Drugs and Devices OW OW Health
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/2yvpXCZ
GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS
news-medical.net — “On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets, a once-daily treatment for moderate-to-severe restless legs syndrome.” View full resource at news-medical.net
Most Recently Shared on April 8, 2011 at 8:27 am By:
Epilepsy News: GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS: On April 6, the U.S. Fo... http://bit.ly/g6qRcu
GlaxoSmithKline And XenoPort Receive FDA Approval For Horizant™ - - New Treatment For Moderate-To-Severe Primary Restless Legs Syndrome
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Rele” View full resource at medicalnewstoday.com
Most Recently Shared on April 7, 2011 at 10:05 am By:
GlaxoSmithKline And XenoPort Receive FDA Approval For Horizant™ - - New Treatment For Moderate-To-Severe Primar... http://mnt.to/3TjT
XenoPort rockets up after FDA approves Horizant for RLS - FierceBiotech
fiercebiotech.com — “After surviving a turbulent year marked by a painful restructuring and a setback in the clinical development of one of its key programs, XenoPort ($XNPT) has won approval for Horizant, a new therapy Read more...” View full resource at fiercebiotech.com
Most Recently Shared on April 7, 2011 at 1:30 pm By:
John Carroll Health Communicator
XenoPort's Barrett tells me that they have 3 yrs to start selling, giving him time to add neurology drugs to portfolio. http://bit.ly/eNsfJ9
FDA Approves XenoPort, Glaxo Drug for Restless Leg Syndrome - FoxNews.com
foxnews.com — “The Food and Drug Administration has approved Horizant, a drug for restless legs syndrome that XenoPort Inc.and GlaxoSmithKline PLC developed together, the companies said in a release” View full resource at foxnews.com
Most Recently Shared on April 8, 2011 at 7:52 pm By:
Health,Fitness,Diet Health Business
FDA Approves XenoPort, Glaxo Drug for Restless Leg Syndrome http://bit.ly/fmFnxp
FDA Approves New Drug to Treat Restless Legs Syndrome | LiveScience
livescience.com — “The FDA approved a new drug to treat restless legs syndrome. The drug could be an option for people who suffer from the disorder.” View full resource at livescience.com
Most Recently Shared on April 10, 2011 at 4:37 pm By:
LiveScience Science Enthusiast
Restless Legs Syndrome Drug Receives FDA Approval http://bit.ly/fP0qxB
Neupro® approved by U.S. FDA for Parkinson's disease and Restless Legs Syndrome
worldpharmanews.com — “World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements.” View full resource at worldpharmanews.com
Most Recently Shared on April 4, 2012 at 1:00 am By:
Jerome P. Lisk, M.D. Doctor, Neurologist, and Physician
Neupro® approved by U.S. FDA for Parkinson's disease and Restless Legs Syndrome: http://t.co/XFmE6ppG via @AddThis
GSK restless leg syndrome drug seen as new treatment for shingles pain
medcitynews.com — “GlaxoSmithKline wants to add treating shingles pain as an indication for restless leg syndrome drug Horizant. Read about GSK's deal with partner XenoPort.” View full resource at medcitynews.com
Most Recently Shared on August 10, 2011 at 12:19 pm By:
GSK asks FDA to approve its restless leg drug Horizant to treat shingles pain. http://bit.ly/od4JAW
GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1838262/XP13512) For RLS
medicalnewstoday.com — “GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA” View full resource at medicalnewstoday.com
Most Recently Shared on February 20, 2010 at 3:08 pm By:
GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1838262/XP13512) For RLS http://mnt.to/3xV4 #sleep
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
